Nader himself said in a proactive video that he believed the stock could be a high 3 digit stock or maybe even over a thousand dollars a share. He didn’t list a time when this would happen. But with approvals come revenue. Once HIV duel therapy becomes approved with its safety record. Other indications will be approved much faster. Especially indications that have no drugs to treat them in their class. Nader wasn’t predicting 20 years out. Something reasonable could be as soon as 5 years but time will tell.